CN Patent

CN108472383B — 具有低npr-c结合的控制释放cnp激动剂

Assigned to Ascendis Pharma Endocrinology Division AS · Expires 2022-07-01 · 4y expired

What this patent protects

本发明涉及具有低NPR‑C亲和性的控制释放CNP激动剂；涉及包含所述控制释放CNP激动剂的药物组合物；它们的用途；和治疗方法。

USPTO Abstract

本发明涉及具有低NPR‑C亲和性的控制释放CNP激动剂；涉及包含所述控制释放CNP激动剂的药物组合物；它们的用途；和治疗方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN108472383B
Jurisdiction: CN
Classification: —
Expires: 2022-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Ascendis Pharma Endocrinology Division AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.